Dr Kay Bradford, PHD | |
670 E 500 N, Logan, UT 84321-4228 | |
(435) 232-0381 | |
(435) 213-3800 |
Full Name | Dr Kay Bradford |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 670 E 500 N, Logan, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124253190 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 3672733902 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kay Bradford, PHD 670 E 500 N, Logan, UT 84321-4228 Ph: (435) 232-0381 | Dr Kay Bradford, PHD 670 E 500 N, Logan, UT 84321-4228 Ph: (435) 232-0381 |
News Archive
Researchers have published results of a study showing a relationship between enrollment in state vocational rehabilitation agency (SVRA) services and return-to-work outcomes for beneficiaries of Social Security Disability Insurance (SSDI). Employment outcomes were better among those who enrolled in SVRA services compared with beneficiaries who did not enroll for these services.
A gene shown to play a role in the aging process appears to play a role in the regulation of the differentiation of embryonic stem cells, according to researchers from the Center for Stem Cell Biology and Regenerative Medicine and the Department of Medicine at Thomas Jefferson University.
Among patients with symptomatic intracranial arterial stenosis (narrowing of an artery inside the brain), the use of a balloon-expandable stent compared with medical therapy (clopidogrel and aspirin) resulted in an increased of stroke or transient ischemic attack (TIA), according to a study in the March 24/31 issue of JAMA.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that combination therapy with epratuzumab and rituximab was effective, with durable complete responses in one-third of evaluable patients, and was very well tolerated by patients with previously untreated follicular lymphoma (FL).
Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.43 per outstanding share of the company's common stock, up $0.01 from $0.42 per outstanding share paid last quarter.
› Verified 1 days ago
Tricia Hill Danielson, M.S., LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 270 N Main St, Logan, UT 84321 Phone: 208-339-2847 Fax: 435-752-1095 | |
Dr. Carly D. L. Lebaron, PH.D., LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 95 Golf Course Rd Ste 105, Logan, UT 84321 Phone: 435-915-6398 | |
Charles K Hinds, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 95 West 100 South, Ste 130, Logan, UT 84321 Phone: 435-752-4646 Fax: 435-755-0579 | |
Daniel Richard Miggin, M.S., L.M.F.T. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 90 E 200 N, Logan, UT 84321 Phone: 435-752-0750 Fax: 435-752-7433 | |
Sarah Anne Blotter, LAMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 273 W 1010 S, Logan, UT 84321 Phone: 801-871-5118 | |
Brian Keith Steiner, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 95 W 100 S, Logan, UT 84321 Phone: 435-752-5302 | |
Mrs. Krystal Cox, B.S. M.F.T.I Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 493 North 700 East, Logan, UT 84321 Phone: 435-797-7224 |